-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Theriva Biologics, Inc. annual/quarterly Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Theriva Biologics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$3.3M, a 26.4% increase year-over-year.
- Theriva Biologics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$18.3M, a 6.79% increase from 2022.
- Theriva Biologics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$19.7M, a 38% decline from 2021.
- Theriva Biologics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$14.3M, a 42.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)